|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/12 | |
| A61K 31/437 | |||
| A61K 31/4745 | |||
| A61P 15/00 | |||
| A61P 15/02 | |||
| A61P 17/00 | |||
| A61P 17/08 | |||
| A61P 17/12 | |||
| A61P 17/16 | |||
| A61P 17/18 | |||
| A61P 31/12 | |||
| A61P 35/00 | |||
| A61P 43/00 |
| (11) | Number of the document | 1889609 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07013703.9 |
| Date of filing the European patent application | 2007-07-12 | |
| (97) | Date of publication of the European application | 2008-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 807669 P | 2006-07-18 | US |
| (72) |
Vallejo, Janet A., US
|
| (73) |
Meda AB,
Pipersväg 2 A / Box 906, 170 09 Solna,
SE
|
| (54) | Immune response modifier foam formulations |
| Immune response modifier foam formulations |